FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  American journal of translational research

• Publication date

  2018-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 29887965PMCID PMC5992558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway.

  2017cited by this paper
• Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells.

  2017cited by this paper
• FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer

  2017cited by this paper
• FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway

  2016cited by this paper
• Cancer statistics in China, 2015

  2016cited by this paper
• The Emerging Hallmarks of Cancer Metabolism.

  2016cited by this paper
• Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

  2016cited by this paper
• FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27.

  2015cited by this paper
• FOXD1 expression is associated with poor prognosis in non-small cell lung cancer.

  2015cited by this paper
• HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway

  2015cited by this paper
• Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer through ERK and β-arrestin pathways.

  2014cited by this paper
• Foxd1 is a mediator and indicator of the cell reprogramming process

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Hallmarks in colorectal cancer: angiogenesis and cancer stem-like cells.

  2014cited by this paper
• ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer

  2013cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• The origins of colorectal carcinoma: specific nomenclature for different pathways and precursor lesions.

  2010cited by this paper
• Molecular origins of cancer: Molecular basis of colorectal cancer.

  2009cited by this paper
• Human FOX gene family (Review).

  2004cited by this paper

• The Senescence-SASP Landscape in Colon Adenocarcinoma: Prognostic and Therapeutic Implications

  2026cites this paper
• Integrated singlecell and bulk RNA-seq analysis identifies a prognostic signature related to inflammation in colorectal cancer

  2025cites this paper
• Crosstalk between the wnt signaling pathway and axon guidance molecules reveals a novel signature for accurately predicting diagnosis, prognosis, and immune landscape in colorectal cancer.

  2025cites this paper
• Enhancing fibroblast–epithelial cell communications: Serpine2 as a key molecule in Fusobacterium nucleatum–promoted colon cancer

  2025cites this paper
• Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma

  2025cites this paper
• Forkhead box D subfamily genes in colorectal cancer: potential biomarkers and therapeutic targets

  2024influential citation
• Evaluation of CacyBP/SIP expression and its relationship with ERK1/2 and p38 kinase in testicular seminoma.

  2024cites this paper
• Spatial transcriptomic revealed intratumor heterogeneity and cancer stem cell enrichment in colorectal cancer metastasis.

  2024cites this paper
• Waterpipe smoke condensate induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by FOXD1 expression.

  2024cites this paper
• Wnt/β-catenin signaling regulates amino acid metabolism through the suppression of CEBPA and FOXA1 in liver cancer cells

  2024cites this paper
• Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers.

  2023cites this paper
• FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization

  2023cites this paper
• Dysregulated Forkhead Box (FOX) Genes Association with Survival Prognosis, Anti-tumor Immunity, and Key Targeting Drugs in Colon Adenocarcinoma

  2023cites this paper
• Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis

  2023cites this paper
• Silencing effects of FOXD1 inhibit metastatic potentials of the PCa via N-cadherin - Wnt/β-catenin crosstalk.

  2022cites this paper
• Bioinformatics analysis reveals immune prognostic markers for overall survival of colorectal cancer patients: a novel machine learning survival predictive system

  2022cites this paper
• The Expression and Survival Significance of FOXD1 in Lung Squamous Cell Carcinoma: A Meta-Analysis, Immunohistochemistry Validation, and Bioinformatics Analysis

  2022cites this paper
• Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer

  2022cites this paper
• Identifying the tumor location-associated candidate genes in development of new drugs for colorectal cancer using machine-learning-based approach

  2022cites this paper
• FOXD1-mTOR Signaling Pathway on Oral Squamous Cell Carcinoma and Its Inhibition by Rosemary Extract (Invitro-Study)

  2022cites this paper
• Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma

  2021cites this paper
• E2F transcription factor 1/small nucleolar RNA host gene 18/microRNA-338-5p/forkhead box D1: an important regulatory axis in glioma progression

  2021cites this paper
• Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC

  2021cites this paper
• FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis

  2021cites this paper
• FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma

  2021cites this paper
• FOXD1 regulates cell division in clear cell renal cell carcinoma

  2021cites this paper
• LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway

  2020cites this paper
• Forkhead promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma.

  2020cites this paper
• FOXD1 Repression Potentiates Radiation Effectiveness by Downregulating G3BP2 Expression and Promoting the Activation of TXNIP-Related Pathways in Oral Cancer

  2020cites this paper
• Increased expression of FOXD1 is associated with cervical nodes metastasis and unfavorable prognosis in oral squamous cell carcinoma.

  2020cites this paper
• FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells

  2020cites this paper
• SP1-mediated long noncoding RNA POU3F3 accelerates the cervical cancer through miR-127-5p/FOXD1.

  2019cites this paper
• Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma

  2019cites this paper
• Novel tumor-suppressor FOXN3 is downregulated in adult acute myeloid leukemia.

  2019cites this paper